Q4 & FY22 Highlights

Attractive operating metrics No. of patients (Mn) No. of samples (Mn) Total Revenue (INR Cr.) Non-covid Revenue (INR Cr.) CAGR: 19% CAGR: 18% CAGR: 25% CAGR: 13% 27.3 1691 66.0 2087 19.4 20.3 1330 47.7 49.7 1581 1257 1330 FY20 FY21 FY22 FY20 FY21 FY22 FY20 FY21 FY22 Consumer brand and Increase in samples with network expansion driving patient volumes patient volumes growth FY20 FY21 FY22 FY22 Revenues increased on account of : - Gains in patient volumes at 35% Non Covid Revenue growth CAGR at 13% Note: Results includes Suburban financials wef 12th Nov 21. On transition from IGAAP to IND AS, revenue adjusted as per IND AS 115. Classification: Restricted 20 Dr Lal PathLabs

View entire presentation